Amyloid β-Protein (Human, 1-28)

Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys
: (Trifluoroacetate Form)
: (M.W. 3262.5) C₁₄₅H₂₀₉N₄₁O₄₆
: Amyloidogenic Segment of Amyloid β-Protein

Package	Price(Yen)	Availability	Quantity
Vial 0.5 mg	15,000	Ships within 1-3 business days
バルク見積もり

Solubility: H₂O (0.1 mM)

D.A. Kirschner, H. Inouye, L.K. Duffy, A. Sinclair, M. Lind, and D.J. Selkoe, Proc. Natl. Acad. Sci. U.S.A., 84, 6953 (1987). (Original; Amyloid-Like Fibril Formation)
B. Klajnert, M. Cortijo-Arellano, J. Cladera, and M. Bryszewska, Biochem. Biophys. Res. Commun., 345, 21 (2006). (Amyloid Fibril Formation)
A. Perálvarez-Marin, A. Barth, and A. Gräslund, J. Mol. Biol., 379, 589 (2008). (Amyloid Fibril Formation)
N.G.N. Milton and J.R. Harris, Micron, 40, 800 (2009). (Amyloid Fibril Formation)
T. Wasiak, M. Ionov, K. Nieznanski, H. Nieznanska, O. Klementieva, M. Granell, J. Cladera, J.-P. Majoral, A.M. Caminade, and B. Klajnert, Mol. Pharm., 9, 458 (2012). (Amyloid Fibril Formation & Neurotoxity)
J.S. Whitson, D.J. Selkoe, and C.W. Cotman, Science, 243, 1488 (1989). (Pharmacol.)
B.A. Yankner, L.K. Duffy, and D.A. Kirschner, Science, 250, 279 (1990). (Pharmacol.)